IntelVasc is a medical technology company focused on addressing the significant issue of peripheral arterial disease (PAD). This condition, often undiagnosed, can lead to serious complications like heart attacks and strokes. CEO & co-founder, Andrew Ortega-Verdaguer, joins this episode to discuss how he plans to lead the business from visionary prototype through to market as the team gears up for first FDA discussions early next year.

The company’s innovative solution involves a minimally invasive sensor,   inserted subcutaneously near to the femoral artery. This sensor, paired with a portable scanner, will enable patients to monitor their vascular health at home. By collecting real-time data on blood flow, the technology can empower patients and clinicians to proactively identify potential issues and intervene early, reducing the risk of major complications.

IntelVasc’s technology has the potential to revolutionize the management of PAD. By providing a convenient and reliable method for monitoring vascular health, the company aims to improve patient outcomes, reduce healthcare costs, and enhance the overall quality of life for individuals with this condition. With additional AI and ML opportunities, this is an exciting medtech story sure to keep you informed and inspired.